Literature DB >> 20823655

Successful allogeneic hematopoietic stem cell transplantation for aggressive NK cell leukemia.

Satoshi Ichikawa1, Noriko Fukuhara, Joji Yamamoto, Makiko Suzuki, Shinji Nakajima, Yoko Okitsu, Katsura Kohata, Yasushi Onishi, Kenichi Ishizawa, Junichi Kameoka, Hideo Harigae.   

Abstract

Aggressive natural killer cell leukemia (ANKL) is a highly aggressive lymphoproliferative disease. An appropriate therapeutic strategy for ANKL remains to be established, but a few case reports have suggested that allogeneic hematopoietic stem cell transplantation (allo-HCT) can be curative. Here, we report a young woman with ANKL showing central nervous system (CNS) invasion, who has been in complete remission for more than a year after allo-HCT following two courses of intravenous chemotherapy and several rounds of intrathecal chemotherapy. Intensive remission induction chemotherapy followed by conventional myeloablative allo-HCT is a promising approach for long-term remission in cases of this aggressive malignancy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20823655     DOI: 10.2169/internalmedicine.49.3814

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  3 in total

1.  Allogeneic Hematopoietic Cell Transplantation for Aggressive NK Cell Leukemia. A Center for International Blood and Marrow Transplant Research Analysis.

Authors:  Mehdi Hamadani; Abraham S Kanate; Alyssa DiGilio; Kwang Woo Ahn; Sonali M Smith; Jong Wook Lee; Ernesto Ayala; Nelson Chao; Parameswaran Hari; Javier Bolaños-Meade; Ronald Gress; Niels Smedegaard Anderson; Yi-Bin Chen; Umar Farooq; Gary Schiller; Jean Yared; Anna Sureda; Timothy S Fenske; Horatiu Olteanu
Journal:  Biol Blood Marrow Transplant       Date:  2017-02-01       Impact factor: 5.742

2.  Aggressive Natural Killer Cell Leukemia in an Adolescent Patient: A Case Report and Literature Review.

Authors:  Rong Yang; Yuan Ai; Chuan Liu; Xiaoxi Lu
Journal:  Front Pediatr       Date:  2022-05-23       Impact factor: 3.569

3.  Flow Cytometric Immunophenotyping Is Sensitive for the Early Diagnosis of De Novo Aggressive Natural Killer Cell Leukemia (ANKL): A Multicenter Retrospective Analysis.

Authors:  Yi Li; Jia Wei; Xia Mao; Qingping Gao; Longlong Liu; Ping Cheng; Limei Liu; Xinhua Zhang; Ke Zhang; Jin Wang; Li Zhu; Jianfeng Zhou; Yicheng Zhang; Li Meng; Hanying Sun; Dengju Li; Mei Huang; Wei Huang; Jinniu Deng; Donghua Zhang
Journal:  PLoS One       Date:  2016-08-02       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.